Quick Answer
Opus Genetics, Inc. reported Common Stock Shares Outstanding of 69.89 million shares for the year ending 2025.
- Opus Genetics, Inc. showed an increase of +121.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: 95.24 million shares | Q3 2011: 95.27 million shares | Q1 2012: 95.35 million shares | Q2 2012: 95.35 million shares | Q3 2012: 95.35 million shares | Q1 2013: 119.43 million shares | Q2 2013: 119.81 million shares | Q3 2013: 134.44 million shares | Q1 2014: 176.64 million shares | Q2 2014: 178.15 million shares | Q3 2014: 178.25 million shares | Q1 2015: 179.21 million shares | Q2 2015: 180.62 million shares | Q3 2015: 180.75 million shares | Q1 2016: 213.17 million shares | Q2 2016: 213.23 million shares | Q3 2016: 237.37 million shares | Q1 2017: 244.99 million shares | Q2 2017: 28.45 million shares | Q3 2017: 28.46 million shares | Q1 2018: 31.74 million shares | Q2 2018: 31.74 million shares | Q3 2018: 31.75 million shares | Q1 2019: 4.02 million shares | Q2 2019: 4.02 million shares | Q3 2019: 4.02 million shares | Q1 2020: 4.02 million shares | Q2 2020: 4.02 million shares | Q3 2020: 4.48 million shares | Q1 2021: 10.93 million shares | Q2 2021: 16.89 million shares | Q3 2021: 17.30 million shares | Q1 2022: 19.21 million shares | Q2 2022: 20.10 million shares | Q3 2022: 20.80 million shares | Q1 2023: 20.95 million shares | Q2 2023: 20.99 million shares | Q3 2023: 22.61 million shares | Q1 2024: 25.09 million shares | Q2 2024: 25.98 million shares | Q3 2024: 26.20 million shares | Q1 2025: 45.48 million shares | Q2 2025: 59.91 million shares | Q3 2025: 64.54 million shares.
- Over the full 16 years of available data (2010 to 2025), Opus Genetics, Inc.'s Common Stock Shares Outstanding has declined by 17.0%.
- Historical annual values: Fiscal year 2025: 69.89 million shares | Fiscal year 2024: 31.57 million shares | Fiscal year 2023: 23.98 million shares | Fiscal year 2022: 20.86 million shares | Fiscal year 2021: 18.85 million shares | Fiscal year 2020: 10.88 million shares | Fiscal year 2019: 2.85 million shares | Fiscal year 2018: 3.12 million shares | Fiscal year 2017: 31.73 million shares | Fiscal year 2016: 23.74 million shares | Fiscal year 2015: 197.41 million shares | Fiscal year 2014: 178.25 million shares | Fiscal year 2013: 146.72 million shares | Fiscal year 2012: 119.43 million shares | Fiscal year 2011: 95.35 million shares | Fiscal year 2010: 84.16 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: